Seagen Inc.
SGENDelisted Dec 14, 2023- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001060736
Seagen Inc. was delisted on Dec 14, 2023; its insiders filed their last Form 4 on Dec 18, 2023; 614 institutions reported holding it in 13F filings for Q3 2023, worth $36.3B in total; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Seagen Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Seagen Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Baker Julian | Director, Other: Former 10% Owner | 0Indirect | Dec 18, 2023 | 0 |
| Baker Felix | Director, Other: Former 10% Owner | 0Indirect | Dec 18, 2023 | 0 |
| Baker Bros. Advisors LP | Director, Other: Former 10% Owner | 0Indirect | Dec 18, 2023 | 0 |
| Baker Brothers Life Sciences LP | Director, Other: Former 10% Owner | 0Indirect | Dec 18, 2023 | 0 |
| 667, L.P. | Director, Other: Former 10% Owner | 0Indirect | Dec 18, 2023 | 0 |
| Baker Bros. Advisors (GP) LLC | Director, Other: Former 10% Owner | 0Indirect | Dec 18, 2023 | 0 |
| Love Ted W | Director | 0 | Dec 15, 2023 | 0 |
| Gryska David W | Director | 0 | Dec 15, 2023 | 0 |
| Welch Daniel G | Director | 0Indirect | Dec 15, 2023 | 0 |
| Simpson Todd E | Chief Financial Officer | 0 | Dec 15, 2023 | 0 |
| Liu Jean I | Chief Legal Officer | 0 | Dec 15, 2023 | 0 |
| Simonian Nancy A | Director | 0 | Dec 15, 2023 | 0 |
| Himes Vaughn B | Chief Technical Officer | 0Indirect | Dec 15, 2023 | 0 |
| Epstein David R | CEO | 0 | Dec 15, 2023 | 0 |
| Orwin John A | Director | 0 | Dec 15, 2023 | 0 |
| Seth Alpna | Director | 0 | Dec 15, 2023 | 0 |
| Dansey Roger D | President, R&D & CMO | 0 | Dec 15, 2023 | 0 |
| Romp Charles R | EVP, Commercial U.S. | 0 | Dec 15, 2023 | 0 |
| Swain Sandra M | Director | 0 | Dec 15, 2023 | 0 |
| Siegall Clay B | President & CEO | 666,060 | May 13, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 9, 2023 (view filing) | Jun 7 | 2 days | Himes Vaughn BChief Technical Officer | SSale | −16.2K | $195.29 | −$3.17M | −27.0%43.8K after | 10b5-1 |
| Jul 5, 2023 (view filing) | Jul 3 | 2 days | Romp Charles REVP, Commercial U.S. | SSale | −708 | $192.46 | −$136.3K | −1.2%59.1K after | 10b5-1 |
| Aug 29, 2023 (view filing) | Aug 28 | 1 day | Welch Daniel GDirector | SSale | −3.31K | $209.08 | −$693.1K | −32.8%6.79K after | 2 lots |
| Aug 29, 2023 (view filing) | Aug 28 | 1 day | Welch Daniel GDirector | SSale | −1.61K | $209.08 | −$336.6K | −13.1%10.7K after | |
| Aug 30, 2023 (view filing) | Aug 29 | 1 day | Liu Jean IChief Legal Officer | SSale | −405 | $206.00 | −$83.4K | −0.5%86.4K after | |
| Aug 30, 2023 (view filing) | Aug 29 | 1 day | Simpson Todd EChief Financial Officer | SSale | −485 | $206.00 | −$99.9K | −0.4%130.9K after | |
| Aug 30, 2023 (view filing) | Aug 29 | 1 day | Romp Charles REVP, Commercial U.S. | SSale | −438 | $206.00 | −$90.2K | −0.6%69.7K after | |
| Aug 30, 2023 (view filing) | Aug 29 | 1 day | Himes Vaughn BChief Technical Officer | SSale | −371 | $206.00 | −$76.4K | −0.7%53.2K after | |
| Aug 30, 2023 (view filing) | Aug 29 | 1 day | Dansey Roger DPresident, R&D & CMO | SSale | −1.02K | $206.00 | −$209.3K | −0.9%115.8K after | |
| Sep 1, 2023 (view filing) | Aug 31 | 1 day | Simpson Todd EChief Financial Officer | SSale | −2.12K | $206.97 | −$439.2K | −1.6%128.8K after | |
| Sep 1, 2023 (view filing) | Aug 31 | 1 day | Romp Charles REVP, Commercial U.S. | SSale | −555 | $206.97 | −$114.9K | −0.8%69.2K after | |
| Sep 1, 2023 (view filing) | Aug 31 | 1 day | Liu Jean IChief Legal Officer | SSale | −1.89K | $206.97 | −$391.8K | −2.2%84.5K after | |
| Sep 1, 2023 (view filing) | Aug 31 | 1 day | Himes Vaughn BChief Technical Officer | SSale | −1.79K | $206.97 | −$371.5K | −3.4%51.4K after | |
| Sep 1, 2023 (view filing) | Aug 31 | 1 day | Dansey Roger DPresident, R&D & CMO | SSale | −4.03K | $206.97 | −$833.9K | −3.5%111.8K after | |
| Sep 8, 2023 (view filing) | Sep 7 | 1 day | Himes Vaughn BChief Technical Officer | SSale | −8.79K | $205.76 | −$1.81M | −14.6%51.4K after | |
| Sep 22, 2023 (view filing) | Sep 21 | 1 day | Simpson Todd EChief Financial Officer | SSale | −80 | $206.50 | −$16.5K | −0.1%128.7K after | |
| Sep 22, 2023 (view filing) | Sep 21 | 1 day | Romp Charles REVP, Commercial U.S. | SSale | −45 | $206.50 | −$9.29K | −0.1%69.1K after | |
| Sep 22, 2023 (view filing) | Sep 21 | 1 day | Liu Jean IChief Legal Officer | SSale | −64 | $206.50 | −$13.2K | −0.1%84.4K after | |
| Sep 22, 2023 (view filing) | Sep 21 | 1 day | Himes Vaughn BChief Technical Officer | SSale | −80 | $206.50 | −$16.5K | −0.2%51.4K after | |
| Sep 22, 2023 (view filing) | Sep 21 | 1 day | Dansey Roger DPresident, R&D & CMO | SSale | −71 | $206.50 | −$14.7K | −0.1%116.7K after | |
| Nov 13, 2023 (view filing) | Nov 9 | 4 days | Himes Vaughn BChief Technical Officer | SSale | −8.79K | $213.32 | −$1.87M | −17.1%42.6K after | 2 lots |
| Nov 13, 2023 (view filing) | Nov 10 | 3 days | Epstein David RCEO | SSale | −10.6K | $213.01 | −$2.26M | −7.2%136.6K after |